Research map: Residual β-cell function is associated with continuous glucose monitoring metrics in patients with type 1 diabetes mellitus

Back to the article

Papers in this map

  1. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025 · Nuha A. ElSayed · 2024 · 1318 citations · Cited by this paper
  2. Subclinical primary aldosteronism: toward a conceptual framework linking primary aldosteronism and low-renin hypertension · 2026 · Related
  3. β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial · Michael W. Steffes · 2003 · 699 citations · Cited by this paper
  4. Physician and hospital determinants of levothyroxine treatment adequacy in low-risk papillary thyroid carcinoma · 2026 · Related
  5. Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study · Hillary A. Keenan · 2010 · 503 citations · Cited by this paper
  6. The effects of SARS-CoV-2 on bone homeostasis · 2026 · Related
  7. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050 · Irini Genitsaridi · 2025 · 441 citations · Cited by this paper
  8. Restless legs syndrome or diabetic peripheral neuropathy: diagnostic dilemmas and clinical insights from a case report · 2026 · Related
  9. Insulin: The master regulator of glucose metabolism · Luke Norton · 2022 · 333 citations · Cited by this paper
  10. Association between metabolic syndrome and mortality among breast cancer survivors: a prospective cohort study · 2026 · Related
  11. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring · Michael Yapanis · 2022 · 297 citations · Cited by this paper
  12. Association of accelerometer-measured physical activity and the risk of incident cardiovascular diseases within the AHA cardiovascular-kidney-metabolic syndrome 0–4 framework: a prospective cohort of the UK Biobank · 2026 · Related
  13. Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial · John M. Lachin · 2013 · 287 citations · Cited by this paper
  14. Association of gravidity, parity, and abortion history with nodal metastasis in women with papillary thyroid carcinoma: a retrospective cohort study · 2026 · Related
  15. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions · David M. Nathan · 2013 · 274 citations · Cited by this paper
  16. Association between primary aldosteronism and type 2 diabetes and identification of potential molecular mechanisms · 2026 · Related
  17. Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes · Asa K. Davis · 2014 · 263 citations · Cited by this paper
  18. Diabetic ketoacidosis associated with pancreatic involvement in a patient with von Hippel-Lindau syndrome: a case report · 2026 · Related
  19. Type 1 Diabetes Mellitus · Fatima Syed · 2022 · 259 citations · Cited by this paper
  20. The immunology of type 1 diabetes · Kevan C. Herold · 2024 · 216 citations · Cited by this paper
  21. C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective · Ernesto Maddaloni · 2022 · 132 citations · Cited by this paper
  22. High residual C-peptide likely contributes to glycemic control in type 1 diabetes · Michael Roehrhoff Rickels · 2020 · 116 citations · Cited by this paper
  23. Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications · Anita Jeyam · 2020 · 116 citations · Cited by this paper
  24. C-peptide: New findings and therapeutic possibilities · John Wahren · 2015 · 115 citations · Cited by this paper
  25. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia · Rose Gubitosi‐Klug · 2021 · 89 citations · Cited by this paper
  26. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study · Jolien De Meulemeester · 2024 · 68 citations · Cited by this paper
  27. Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes · Fraser W. Gibb · 2020 · 66 citations · Cited by this paper
  28. Advances in Continuous Glucose Monitoring: Clinical Applications · So Yoon Kwon · 2025 · 58 citations · Cited by this paper
  29. The role of C-peptide in diabetes and its complications: an updated review · Jintao Chen · 2023 · 50 citations · Cited by this paper
  30. Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation · Lúcia Fadiga · 2020 · 20 citations · Cited by this paper
  31. A little help from residual β cells has long-lasting clinical benefits · Anna P. Lam · 2021 · 18 citations · Cited by this paper
  32. Revisiting the Pattern of Loss of β-Cell Function in Preclinical Type 1 Diabetes · Mariangela Martino · 2024 · 18 citations · Cited by this paper
  33. The Role of Glucagon in Glycemic Variability in Type 1 Diabetes: A Narrative Review · Keyu Guo · 2021 · 15 citations · Cited by this paper
  34. Capturing residual beta cell function in type 1 diabetes · Flemming Pociot · 2018 · 12 citations · Cited by this paper
  35. TMEM219 regulates the transcription factor expression and proliferation of beta cells · Francesca D’Addio · 2024 · 12 citations · Cited by this paper
  36. Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta‐analysis of randomized controlled trials · Gabriel Grando Alves · 2024 · 12 citations · Cited by this paper
  37. A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus · Antonio Rossi · 2024 · 11 citations · Cited by this paper
  38. Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes · Ernesto Maddaloni · 2024 · 7 citations · Cited by this paper
  39. Association of detectable C-peptide levels with glycemic control and chronic complications in individuals with type 1 diabetes mellitus: A systematic review and meta-analysis · Mahin Seifi Alan · 2024 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)